Clinical Trial: Topical 0.4% Ketorolac and Vitreoretinal Surgery
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Topical 0.4% Ketorolac for the Inhibition of Miosis During Vitreoretinal Surgery: a Randomized, Placebo-controlled, Double-masked Study
Brief Summary: To determine whether use of topical 0.4% ketorolac has any effect on pupil size during vitreoretinal surgery.
Detailed Summary: Other outcomes will be to assess postoperative pain and inflammation and visual acuity.
Sponsor: Emory University
Current Primary Outcome: Change in pupil size during vitreoretinal surgery [ Time Frame: Surgery ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Postoperative pain and inflammation [ Time Frame: 1 day ]
Original Secondary Outcome: Same as current
Information By: Emory University
Dates:
Date Received: December 17, 2007
Date Started: November 2006
Date Completion:
Last Updated: May 12, 2014
Last Verified: May 2014